cost comparison glp 1 Growth, Volume, Price: The Skinny on GLP-1 Medications - Survey Finds: GLP-1 Users Cut

In the latest, researchers from the Cleveland Clinic compared patients who were prescribed a GLP-1 drug for obesity or type 2 diabetes to those on non-GLP-1 meds

The brawl at hand is over GLP-1 drugs like Ozempic and Mounjaro that were developed for diabetes but have found massive reach for weight loss

For FDA-approved tirzepatide, LillyDirect Zepbound vials at ~$499/mo self-pay is the manufacturer-direct benchmark

In the ad, which you can find here, the two actors participate in "GLP-1 Trivia," where Justin represents Ozempic and Hodgman represents "Other GLP-1s for type 2 diabetes." The presenter asks them to name "the only GLP-1 for type 2 diabetes that's FDA-approved to lower the risk of worsening chronic kidney diseases," to which the "Other GLP-1 for type 2 diabetes" participant responds: "Ozempic." The more confounding part of the ad comes next, as Justin Long spends nearly three minutes reading the important safety information about the medication